Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Pfizer
(NY:
PFE
)
25.26
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Pfizer
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Rising Dividend Make Zoetis a Doggone Winner
August 03, 2023
Investors that typically focus on other large cap pharmaceutical plays may wish to consider an alternative bet on pets with shares of Zoetis.
Via
MarketBeat
Pfizer Reports Second-Quarter 2023 Results
August 01, 2023
From
Pfizer Inc.
Via
Business Wire
Arvinas and Pfizer Awarded Innovation Passport Designation by the U.K. Innovative Licensing and Access Pathway Steering Group for Vepdegestrant, an Investigational PROTAC® ER degrader being developed in ER+/HER2- Breast Cancer
July 31, 2023
Designation indicates entry into the U.K.’s Innovative Licensing and Access Pathway (ILAP)
From
Arvinas Inc.
Via
GlobeNewswire
Pfizer Inc. (NYSE: PFE) is One of Monday Morning’s Most Active Stocks
June 26, 2023
Via
Investor Brand Network
Exposures
COVID-19
2 Attractive Large Caps on Sale After Q2 Earnings
July 31, 2023
For investors that like to sift through the underperformers for good values, good factors to identify are market overreaction and healthy long-term outlooks.
Via
MarketBeat
Topics
Economy
Exposures
Interest Rates
Australian GP sues Pfizer and Moderna over alleged GMOs in mRNA Covid-19 vaccines
July 29, 2023
July 29, 2023 -- An Australian doctor and pharmacist is seeking an injunction from the Federal Court to stop Pfizer and Moderna from distributing their mRNA Covid-19 vaccines
Via
24-7 Press Release
Topics
Lawsuit
Exposures
COVID-19
Financial
Legal
7 Best Cancer Stocks to Invest in Now
July 28, 2023
The second-largest cause of death in the U.S., more than 600,000 deaths from cancer will occur in 2023. Learn about the best cancer stocks to invest in now.
Via
MarketBeat
Topics
Death
Exposures
Death
Pfizer Announces Executive Leadership to Advance Oncology Research and Development Strategy
July 27, 2023
From
Pfizer Inc.
Via
Business Wire
Lifestyle Drugs Market to See Huge Growth by 2028 : Alkermes, AstraZeneca, Pfizer, BMS
July 25, 2023
Lifestyle Drugs Comprehensive Study by Type (Depression, Dermatology, Sexual dysfunction, Obesity), Application (Children, Adults, Senior Citizens), Form (Tablets, External Use, Injection) Players and...
Via
SBWire
Exposures
Product Safety
AI for Pharma and Biotech Market May Set Massive Growth by 2030
July 24, 2023
Get a view on AI for Pharma and Biotech Market sales by marketing channels. Target important market by region and tap important dynamics of this industry.
Via
SBWire
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
MarketBeat Week in Review – 7/17 - 7/21
July 22, 2023
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
Pfizer Announces Post-Tornado Relief Plans for Rocky Mount Community and Manufacturing Facility
July 21, 2023
From
Pfizer Inc.
Via
Business Wire
3 Undervalued Large-Cap Stocks That Won't Be for Long
July 20, 2023
Buying undervalued stocks that have unrealized catalysts will rarely disappoint investors who have the discipline to hold them over time.
Via
MarketBeat
Exposures
COVID-19
Pfizer Announces New England Journal of Medicine Publication on Group B Streptococcus (GBS) Maternal Vaccine Candidate
July 19, 2023
From
Pfizer Inc.
Via
Business Wire
MarketBeat Week in Review – 7/10 - 7/14
July 15, 2023
As inflation moderates, Investors are optimistic for the second quarter earnings season and that optimism is evident in some of the top stories from this week
Via
MarketBeat
Topics
Economy
Exposures
Economy
Interest Rates
3 Biotech Stocks to Buy for Long-Term Gains
July 13, 2023
The biotech sector is one of the most volatile sectors, but here are three biotech stocks that offer opportunities for patient biotech stock investors.
Via
MarketBeat
Topics
ETFs
Economy
Exposures
Interest Rates
Pfizer Just Invested $25 million In This Biotech
July 07, 2023
Pfizer's investment propels Caribou Biosciences' stock and fuels optimism for its lead candidates: CB-010 and CB-011, both currently in phase 1 trials.
Via
MarketBeat
Pfizer (NYSE: PFE) Invests $25 Million in Caribou Biosciences (NASDAQ: CRBU)
July 06, 2023
On July 6, 2023, Caribou Biosciences, Inc., a significant player in the field of CRISPR genome-editing biopharmaceuticals, announced a $25
Via
Spotlight Growth
Carrick Therapeutics Announces Clinical Trial Collaboration with Arvinas and Pfizer to Evaluate Samuraciclib and Vepdegestrant Combination
July 06, 2023
Collaboration expands Carrick’s clinical-stage Oncology program
From
CARRICK THERAPEUTICS LIMITED
Via
GlobeNewswire
Caribou Biosciences Announces $25 Million Equity Investment from Pfizer
July 06, 2023
From
Caribou Biosciences, Inc.
Via
GlobeNewswire
Chronic Plaque Psoriasis Market and Epidemiology 2032: Treatment Therapies, FDA Approvals, Companies and Patient based Forecast by DelveInsight | Dermavant Sciences, Pfizer, Arcutis Biotherapeutics
July 05, 2023
Via
AB Newswire
Exposures
Product Safety
Hemophilia A Market expected to rise | Companies – Hoffmann-La Roche, Chugai Pharmaceutical, Shire, Pfizer, BioMarin Pharmaceutical, Sinocelltech Ltd., Bayer, Ultragenix pharmaceutical
July 03, 2023
Via
AB Newswire
Immunome (NASDAQ: IMNM) and Morphimmune Announce Merger to Develop Best-in-Class Targeted Cancer Therapies
June 29, 2023
Via
Spotlight Growth
Exposures
Product Safety
FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
June 28, 2023
From
Pfizer Inc.
Via
Business Wire
Pleural Effusion Market: Analysis of Epidemiology, Pipeline Therapies, and Key Companies|Companies – Lung Therapeutics, Carefusion, Pfizer, Roche
June 27, 2023
Via
AB Newswire
Activision Blizzard Shares up 1.83% Amid Regulators' Blunders
June 27, 2023
Shares of Microsoft Corp. (NASDAQ: MSFT) declined 1.92% on June 26, more than the broader market, while Activision Blizzard Inc. (NASDAQ: ATVI) rose 1.83%. The S&P 500 declined 0.41% in the session.
Via
MarketBeat
Topics
Stocks
Exposures
US Equities
Lipodystrophy Pipeline Drugs Analysis Report, 2023: FDA Approvals, Clinical Trials, Therapies, by DelveInsight | Regeneron, Ionis, Pfizer, Amunix, Zydus Cadila, Galmed, CombiGene, Carmot Therapeutics
June 27, 2023
Via
AB Newswire
Exposures
Product Safety
FDA Accepts Pfizer’s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
June 27, 2023
From
Pfizer Inc.
Via
Business Wire
Non Muscle Invasive Bladder Cancer Pipeline and Clinical Trials Analysis 2023 (Updated): 25+ Companies are working to improve the Treatment of Space | Pfizer, Janssen, Protara, Merck
June 27, 2023
Via
AB Newswire
Duchenne Muscular Dystrophy Market expected to rise | Companies – Sarepta Therapeutics, PTC Therapeutics, Nippon Shinyaku, Pfizer, Santhera Pharmaceuticals/ReveraGen BioPharma, Taiho Pharmaceutical
June 27, 2023
Via
AB Newswire
< Previous
1
2
3
4
5
6
7
8
9
...
31
32
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.